Business Context and Reporting Period
This Form 8-K filing by SANUWAVE Health, Inc. (the "Company") covers the event date of February 27, 2024. The report details an amendment to a previously disclosed Agreement and Plan of Merger entered into on August 23, 2023, with SEP Acquisition Corp. ("SEPA") and its wholly-owned subsidiary, SEP Acquisition Holdings Inc. ("Merger Sub"). The transaction involves Merger Sub merging with and into the Company, with the Company continuing as a wholly-owned subsidiary of SEPA.
Key Financial Metrics
This filing is a current report regarding a material definitive agreement and does not contain financial statements (e.g., revenue, profit, cash flow, margins, debt, or liquidity metrics) for the Company or SEPA. The document references a financial condition precedent for the closing of the transaction but does not report current financial performance.
Material Changes
The primary material change reported is the execution of Amendment Number One to the Merger Agreement. Key details include:
- Extension of Outside Date: The "Outside Date," which is the deadline after which either party may terminate the agreement if closing conditions are not met, has been extended from February 28, 2024 to April 30, 2024.
- No Other Changes: The filing explicitly states that no other changes were made to the original Merger Agreement.
Guidance, Outlook, Risks, and Contingencies
The filing includes standard forward-looking statements and identifies specific risks and contingencies related to the proposed Business Combination:
- Closing Conditions: A critical condition for closing is that SEPA must have at least $12.0 million at closing. This amount must result from proceeds of (a) SEPA's Class A common stock that has not been redeemed and (b) a private placement.
- Termination Risks: The transaction may be terminated if conditions are not satisfied or waived by the new Outside Date, or due to regulatory approval delays.
- Listing Risks: There is a risk regarding the inability to obtain or maintain the listing of SEPA's securities on Nasdaq following the transaction.
- Forward-Looking Caution: The Company cautions that actual results may differ materially from expectations due to factors outside their control, including economic conditions and competitive factors.
Investor Verification Checklist
- Verify the status of SEPA's $12.0 million closing condition (unredeemed stock proceeds and private placement status).
- Review the full text of Amendment Number One filed as Exhibit 2.1 for any nuanced legal terms not summarized here.
- Consult the Form S-4 registration statement and the definitive proxy statement filed by SEPA and the Company for comprehensive risk factors and transaction details.
- Monitor for updates on Nasdaq listing requirements for the combined entity.
- Confirm the timeline for the new April 30, 2024 Outside Date and any potential further extensions.